探讨依达拉奉治疗急性脑梗死的临床效果观察

摘要

Objective To investigate the clinical effect of edaravone in the treatment of acute cerebral infarction patients.Methods 68 cases of patients with acute cerebral infarction admitted to our hospital from February 2013 to June 2015 were selected as the research subjects, patients received edaravone therapy were analyzed. Results After treatment, 10 cases of cured patients, significant progress was made in 17 patients, 16 cases of progressive patients, no change in 17 cases,deterioration and death in 8 cases. Before treatment, the average NIHSS score (22.2 ± 8.5) points. After 2 weeks of treatment, the average NIHSS score was (14.2 ± 5.2) points. Before and after treatment, the difference of NIHSS score was statistically signiifcant (P<0.05).Conclusion Edaravone in treatment of acute cerebral infarction can alleviate neurological deifcit, to improve the effectiveness of other treatment modalities, the effect of brain nerve protective agent was improved.%目的：探讨急性脑梗死患者接受依达拉奉治疗的临床效果。方法选取2013年2月～2015年6月我院收治的68例急性脑梗死患者作为研究对象，对患者接受依达拉奉治疗的效果进行分析。结果经过治疗后，基本痊愈患者10例，显著进步患者17例，进步患者16例，无变化17例，恶化或死亡8例。治疗前，患者平均NIHSS评分（22.2±8.5）分，治疗2周后，患者平均NIHSS评分（14.2±5.2）分，治疗前后的NIHSS评分对比，差异具有统计学意义（P＜0.05）。结论依达拉奉治疗急性脑梗死能够缓解神经功能缺损情况，提升其他治疗方式的效果，对脑神经保护剂有提升疗效的作用。